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Abstract 
 Background: In malaria endemic areas, pregnant women are 
constantly at risk of repeated malaria infestation which if left untreated, poses 
a significant threat to the health and survival of the mother and her baby. 
Objective: This study determined the prevalence and risk factors for placental 
malaria parasitaemia among parturients at the Federal Medical Centre, 
Yenagoa, Nigeria. Methodology: A prospective cross-sectional analytical 
study of 205 parturients recruited consecutively at presentation for delivery. 
An interviewer-administered questionnaire was used to collect data. After 
delivery, placental blood was collected for microscopy to detect malaria 
parasites. Data was analysed using SPSS version 22. Results: The prevalence 
of placental malaria parasitaemia was 13.7%. Maternal age <25 years 
(P<0.001), low educational status (P = 0.03), low parity (P = 0.03), unbooked 
status (P < 0.001) and non-use of intermittent preventive treatment (P <0.001) 
were significantly associated with placental malaria parasitaemia. Receiving 
three or more doses of sulphadoxine-pyrimethamine for intermittent 
preventive treatment of malaria in pregnancy was by far, more protective for 
placental malaria than receiving 2 doses (odds ratio = 0.25). Plasmodium 
falciparum was the only parasite species detected. Conclusion: Malaria still 
ravages our obstetric population and the significant contributors include low 
maternal age, low educational status, low parity, unbooked status and non-use 
of intermittent preventive treatment in pregnancy. Women should be 
encouraged to utilize antenatal care. There should be a prompt adoption of the 
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recent WHO recommendations regarding malaria prophylaxis in pregnancy in 
all obstetric units and the medication should be given as Directly Observed 
Therapy. 
Keywords: Placental malaria, Placental malaria parasitaemia, Placental 
parasitization 
 
Introduction 
 Malaria during pregnancy is a global public health problem that 
remains a significant threat to the health and survival of the mother, foetus and 
neonate.(Atta & Reeder, 2014; World Health Organaization, 2014) The most 
important complications are maternal anaemia, foetal death and intrauterine 
growth restriction leading to low birth weight.  
 The burden is highest in sub-Saharan Africa where it is responsible for 
26% of severe anaemia in pregnancy, and up to 1 out of every 4 women have 
evidence of placental infection at delivery. It is also responsible for 35% of 
preventable low birth weight neonates; 9-fold risk of neonatal death and 3-17 
infant deaths per 1000 live births.(Desai et al., 2007) 
 These Complications are described as consequences of placental 
sequestration (also called placental malaria).(Autino et al., 2012) Infected 
erythrocytes have ability to adhere to chondroitin sulphate A on the 
syncytiotrophoblasts of the placenta(Autino et al., 2012) and because of this 
placental sequestration, peripheral blood film microscopy underestimates the 
prevalence of malaria in pregnancy.(Fried et al., 2012) This also is responsible 
for missed diagnosis and delay in instituting treatment with resultant 
potentiation of adverse effects of malaria in pregnancy.(Fried et al., 2012) 
Because of the above, microscopy of placental blood is thus, more sensitive in 
the diagnosis of maternal malaria than peripheral blood film 
microscopy.(Fried et al., 2012) More so, the presence of placental malaria 
parasitaemia at delivery is an indication that placental sequestration was either 
not prevented, cleared promptly or recurrent because of poor malaria 
prevention during pregnancy. 
 The prevalence of placental malaria varies. Using placental blood film 
microscopy, it averages 25% in sub-Saharan Africa.(Desai et al., 2007) The 
prevalence in Nigeria is higher in the South-East region (as high as 
64.4%)(Aribodor et al., 2009) than in other regions (11.3 to 25%).(Falade et 
al., 2007; Falade et al., 2010; Inyang-Etoh et al., 2011; Kolawole, 2009; 
Mokuolu et al., 2009) A recent study (in 2015) at the University of 
Portharcourt Teaching Hospital however reported an alarming prevalence of 
65.2% among 210 parturients.(Bassey et al, 2015) These variations in 
prevalence may be due to variations in community acquired immunity, socio-
demographic characteristics of study population, case selection, quality of 
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antenatal care, use of malaria preventive measures, resistance to antimalarial 
drugs and diagnostic tools employed for parasite detection.(Bassey et al., 
2015) 
 Documented risk factors for placental malaria include young maternal 
age, nulliparity/primiparity, non-use of malaria preventive measures and HIV 
infection.(Bassey et al., 2015; Briand et al., 2009; Oraneli et al., 2013; Tako 
et al., 2005) 
 The preventive measures postulated by the World Health Organization 
include use of insecticide-treated bed nets, intermittent preventive treatment 
of malaria in pregnancy and effective case management with potent 
antimalarial drugs.(Olumese, 2014) The current intermittent preventive 
therapy for malaria during pregnancy as postulated by the Nigerian Federal 
Ministry of Health in 2014, is the use of at least three doses of sulphadoxine-
pyrimethamine (SP) combination, given not less than four weeks apart, in the 
second and third trimesters of pregnancy.(Federal Ministry of Health 
[Nigeria], 2014) These preventive measures are recommended to be available 
in every malaria endemic environment.(Olumese, 2014) Meta-analysis of 
intervention trials(Garner & Gülmezoglu, 2006) suggests that prevention of 
malaria in pregnancy (with the above measures) reduces the risk of severe 
anaemia, LBW and perinatal mortality by 38%, 43% and 27% respectively. 
As such, the World Health Organization encourages local research (such as 
this) and collaboration between scientists, policy makers and health 
institutions where the control programs are offered. This helps to guide the 
prevention programs as well as monitor and evaluate markers of successful 
prevention. 
 It is hoped that the findings, conclusions and recommendations from 
this study serve as additional advocacy for the need for policy makers to 
institute widespread coverage of malaria prevention strategies in pregnancy; 
attending physicians to ensure adherence to malaria prevention guidelines; and 
antenatal clients to comply with malaria preventive measures. These will 
ultimately lead to reduction in malaria associated morbidity and mortality and 
improvements in maternal, foetal and child health. 
 
Objectives 
 The objectives of this study were to determine the prevalence of 
placental blood malaria parasitaemia at delivery among parturients and 
determine the risk factors associated with placental malaria parasitization at 
the Federal Medical Centre, Yenagoa. 
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Methodology 
Study location  
 This study was conducted at the Federal Medical Centre, Yenagoa, the 
capital city of Bayelsa State in the South-South region of Nigeria.  
 
Study design 
 This was a prospective cross-sectional analytical study. 
 
Study Population 
 This consisted of both booked and unbooked parturients 
 
Inclusion Criteria 
 All pregnant women presenting to the labour ward (for delivery), who 
give consent to participate in the study. 
 
Exclusion Criteria 
 Parturients who declined participation or do not give consent. 
 
Sample size calculation  
 The sample size for this study was calculated using the formula for 
cross-sectional studies(Araoye, 2003) N = [Z2 P(1-P)] / d2, Where, N = Sample 
size; Z = Proportion of normal distribution corresponding to the required (5%) 
significance level (which is 1.96);  P = Prevalence of placental malaria 
parasitaemia, which is 14% or 0.14 from a previous study(Mokuolu et al., 
2009) and d = Degree of accuracy/ precision expected (0.05) 
 Thus, N= 1.962 x 0.14 (1-0.14)/ 0.052 = 185.5 
 The sample size was thus calculated to be 186. Giving allowance for a 
10% attrition rate, the minimum sample size for the study was 205 
participants. 
 The data for this study was collected over a period of five months 
(August 1, 2016 to December 31, 2016). 
 
Sampling methodology 
 Every consecutive parturient who satisfied the eligibility criteria and 
gave consent was recruited until the sample size was obtained. 
 
Study Protocol 
 With the study protocol in mind, standard laboratory methods as 
described by Cheesbrough(Cheesbrough, 2009)  was used. 
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Data collection 
 After obtaining a signed informed consent from the eligible 
participant, a semi-structured interviewer-administered questionnaire was 
filled. The questionnaire contained information that includes maternal age, 
marital status, educational status, occupation, gravidity, antenatal care, 
malaria preventive measures, infant birth weight and placental blood 
microscopy for malaria parasite detection as well as parasite density. 
 
Placental blood collection 
 The aspiration method of placental blood collection(Othoro et al., 
2006) was employed. This was done immediately after delivery of the 
placenta. The placenta (with its maternal surface facing up) was placed on a 
smooth surface. The maternal placental surface was washed with 200 
millilitres of normal saline, and pierced (to a depth of about 0.5cm) with a 
sterile disposable syringe on a 14-gauge hypodermic needle. Two millilitres 
of placental blood was aspirated and put into an EDTA bottle. The specimen 
was labelled to correspond with the code on the questionnaire (for easy 
identification) and sent to the laboratory for processing (smearing, staining 
and microscopic examination).  
 
Laboratory procedure 
Preparation and staining of the thick blood smear 
 Two drops of placental blood sample were placed on a slide using a 
small rubber pipette. Using the edge of a second slide, the drops of blood were 
joined and spread to make an even, thick smear and allowed to air-dry. The 
slide was immersed in the staining trough, containing 10% of freshly prepared 
Giemsa solution at pH 7.2 and contact maintained for 10 minutes. The slide 
was then removed and allowed to dry. 
 
Preparation and staining of the thin blood smear 
 One drop of placental blood was placed on a clean slide using a rubber 
pipette. The edge of a second slide held steadily at an angle of 45º to the first 
was used to spread the drop of blood to create the thin blood film. The thin 
film was fixed using Methanol (methyl alcohol) by maintaining contact with 
methanol for 10 seconds. The slide was then immersed in the staining trough 
containing 10% of freshly prepared Giemsa solution at pH 7.2 and contact was 
maintained for 10 minutes. The slide was then removed and allowed to dry. 
 
Microscopic examination of slides for malaria parasite and determination 
of parasite density 
 The stained placental blood smears were examined under × 100 oil 
immersion lens of a light microscope. Malaria diagnosis was based on 
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identification of asexual stages of Plasmodium species on the thick blood 
smear while the thin blood smear was used for species identification.  
 Parasite density was determined by counting the number of parasites 
per high power field in the thick blood smear and reported as follows: + (1–
10 parasites per 100 high power fields), ++ (11 – 100 parasites per 100 high 
power fields), +++ (1–10 parasites per high power field), and ++++ (>10 
parasites per high power field). 
 The slide was reported as negative if no parasite was identified per 100 
high power fields. 
 
Data Analysis 
 Data regarding maternal age, marital status, educational status, 
occupation, parity/gravidity, antenatal care, malaria preventive measures, 
infant birth weight and placental blood microscopy for malaria parasite 
detection as well as parasite density was entered and statistical analysis  done 
using statistical software (SPSS for windows® version 22.0, SPSS Inc.; 
Chicago, USA). Univariate analysis for categorical variables was performed 
using chi-square test. P value less than 0.05 was taken as being statistically 
significant. 
 
Ethical Consideration 
 Ethical approval for this study was obtained from the ethical review 
board of the Federal Medical Centre, Yenagoa. A written informed consent 
was also obtained from every participating woman. Participants were not 
responsible for funding the tests.   
 
Results 
Maternal socio-demographic characteristics 
 The maternal socio-demographic characteristics are shown in Table 1. 
Two hundred and five parturients participated in the study. Their ages ranged 
from 14 to 45years with a mean age of 29.9years. The modal age group was 
30-34 years followed by the 25-29 years age group. The majority of the 
parturients had tertiary level of education (53.6%), were married (93.7%) and 
employed (71.7%). Christians constituted 95.6% and the remaining 4.4% were 
Muslims. More than half (57.1%) were of the Ijaw ethnic group; the rest were 
Ibo (31.7%), Yoruba (4.9%), Hausa (1%) and other Nigerian tribes (5.3%). 
The maternal heights ranged from 1.45m-1.66m with an average height of 
1.58±0.05m. 
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Table 1: Maternal socio-demographic characteristics 
 Frequency Percentage 
Age group   
 10-14 1 0.5 
 15-19 6 2.9 
 20-24 32 15.6 
 25-29 54 26.3 
 30-34 58 28.3 
 35-39 50 24.4 
 40-44 3 1.5 
 45-49 1 0.5 
 Total 205 100.0 
Educational status   
No formal education 2 1.0 
Primary 18 8.8 
Secondary 75 36.6 
Tertiary 110 53.6 
Total 205 100.0 
Marital status   
 Single 13 6.3 
 Married 192 93.7 
 Total 205   100.0 
Employment status   
 Unemployed 58 28.3 
 Employed 147 71.7 
 Total 205 100.0 
Religion   
 Christianity 196 95.6 
 Islam 9 4.4 
 Total 205 100.0 
Tribe   
 Ijaw 117 57.1 
 Yoruba 10 4.9 
 Ibo 65 31.7 
 Hausa 2 1.0 
 Others 11 5.3 
 Total 205 100.0 
Maternal height   
 Less than 150cm 18 8.8 
 151-160cm 185 90.2 
 Greater than 160cm 2 1.0 
 Total 205 100.0 
 
Obstetric Profile 
 As illustrated in Table 2, nearly half (40%) of the parturients were 
multiparous. The average parity was 2.13 (Range = 0-6). One hundred and 
eighty one (88.3%) parturients were booked while 24(11.7%) were unbooked. 
The majority (76.2%) booked for antenatal care during the second trimester of 
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pregnancy, 8.3% did so in the first trimester while 15.5% booked during the 
third trimester. The average gestational age at booking was 22±7 weeks. Of 
all the parturients, 76.1% had at least four antenatal clinic visits, 11.7% had 
none and corresponded to the unbooked parturients. The average gestational 
age at delivery was 38.5±1.9weeks (Range = 31-42weeks); of these, 
190(92.7%) parturients delivered at term, 13(6.3%) delivered before term and 
2(1.0%) delivered post-term. 
Table 2: Obstetric profile 
 Frequency Percentage 
Parity   
 Nulliparous 57 27.8 
 Primiparous 58 28.3 
 Multiparous 82 40.0 
 Grand multiparous 8 3.9 
 Total 205 100.0 
Booking status   
 Unbooked 24 11.7 
 Booked 181 88.3 
 Total 205 100.0 
Trimester at booking (n=181)   
 First trimester 15 8.3 
 Second trimester 138 76.2 
 Third trimester 28 15.5 
 Total 181 100.0 
Number of ANC visits   
 None 24 11.7 
 One 6 2.9 
 Two 9 4.4 
 Three 10 4.9 
 Four and above 156 76.1 
 Total 205 100.0 
Gestational age at delivery   
 Preterm 13 6.3 
 Term 190 92.7 
 Post term 2 1.0 
 Total 205 100.0 
ANC = Antenatal Clinic 
 
Malaria control measures (table 3) 
a) Intermittent preventive therapy with Sulphadoxine-
Pyrimethamine (IPTpSP): All the 181 booked parturients (88.3% of the 
participants) had IPTpSP; 16.1% had only one dose, 50.7% had two doses and 
21.5% had at least, three doses. None of the unbooked parturients (11.7% of 
the participants) had IPTpSP or any other form of malaria chemoprophylaxis. 
The parturients who booked late in the third trimester (from 32 weeks of 
gestation and beyond) contributed to the number of women that had just one 
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or two doses of IPTpSP, the remainder booked early but were not compliant 
with the prescription.  
b) Insecticide-treated net (ITN) use: About half (50.2%) of the 
respondents slept under ITNs but only 30.7% did so consistently. 
c) Other measures: Other forms of vector control/malaria preventive 
measures used by respondents were indoor residual spraying with insecticides 
(72.7%) and use of mosquito coils (22%). Majority (98.5%) of the respondents 
had door and window nets at home. 
d) Malaria case treatment: Fifty nine (28.8%) respondents were treated 
for symptomatic malaria during pregnancy. Arthemeter-Lumefantrine 
combination was the most common antimalarial used by 27.8% of the 
respondents while the remaining 1% took quinine. 
Table 3: Malaria control measures 
 Frequency Percentage 
IPTpSP   
 No use 24 11.7 
 1 dose 33 16.1 
 2 doses 104 50.7 
 3 or more doses 44 21.5 
Insecticide Treated Net   
 No use 102 49.8 
 Occasional use 40 19.5 
 Consistent use 63 30.7 
Insecticide spray   
 Does not use 56 27.3 
 Uses less than once a week 58 28.3 
 Uses once a week 32 15.6 
 Uses twice a week or more 59 28.8 
Mosquito coils   
 Does not use 160 78.0 
 Uses less than once a week 18 8.8 
 Uses once a week  8 3.9 
 Uses twice a week or more 19 9.3 
Door and window netting   
 Absent 11 5.4 
 Present 194 94.6 
Malaria drug treatment   
 None 146 71.2 
 Quinine 2 1.0 
 Artemether/Lumefantrine 57 27.8 
 
Prevalence and pattern of placental malaria parasitaemia 
 Two hundred and five placental blood films were analysed. Malaria 
parasite was detected in 28(13.7%) placental blood films and all had mild (+) 
parasitaemia. Plasmodium falciparum was the only malaria species detected 
in all the placental blood films. 
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Risk factors for placental malaria parasitaemia 
 As depicted in table 4, maternal age of less than 25 years; primary or 
no education; nulliparity and primiparity; unbooked status and non-use of 
intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTpSP) 
were shown to have a significant association with the detection of malaria 
parasite in the placental blood sample. 
 Other risk factors that were assessed and found not to be significantly 
associated with placental blood parasitaemia were marital status, maternal 
employment status,  husband’s educational status, husband’s employment 
status, malaria case treatment in pregnancy, insecticide-treated net (ITN) use, 
presence of nets on doors and windows at home, use of insecticide sprays and 
use of mosquito coils. 
 After multivariate logistic regression analysis, the variables 
statistically and independently significant were maternal age of less than 25 
years [odds ratio = 4.19(1.56-11.22)]; low parity including nulliparity [odds 
ratio = 2.7(0.84-8.77)] and primiparity [odds ratio = 2.05(0.62-6.75)]; and 
non-use of intermittent preventive treatment with sulphadoxine-
pyrimethamine [odds ratio = 3.43(1.07-11.00)]. 
Table 4: Risk factor analysis 
 MP +ve 
N(%) 
MP-ve 
N(%) 
Total  
N 
OR(95% CI) X2 df P-
value 
Age group     15.81 1 0.00* 
 <25 years 13(33.3) 26(66.7) 39 5.03(2.15-11.79)    
 ≥25 years 15(9.0) 151(91.0) 166     
Educational 
status 
    5.02 1 0.03* 
 Primary or less 6(30.0) 14(70.0) 20     
 At least 
secondary 
22(11.9) 163(88.1) 185 0.32(0.11-0.91)    
Marital status     0.35 1 0.69 
 Single 2(15.4) 11(84.6) 13 0.86(0.18-4.12)    
 Married 26(13.5) 166(86.5) 192     
Employment 
status 
    0.53 1 0.39 
 Unemployed 6(10.3) 52(89.7) 58     
 Employed 22(15.0) 125(85.0) 147 0.66(0.39-1.17)    
Husband’s 
educ. Stat. 
    0.38 1 0.54 
 Primary or less 2(20.0) 8(80.0) 10 1.65(0.33-8.22)    
 At least 
secondary 
24(13.2) 158(86.8) 182     
Husband’s 
empl. Stat. 
    0.32 1 0.57 
 Unemployed 0(0.0) 2(100.0) 2     
 Employed 26(13.7) 164(86.3) 190     
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Parity     6.89 2 0.03* 
 Nulliparous 10(17.5) 47(82.5) 57 2.98(1.02-8.70)    
 Primiparous 12(20.7) 46(79.3) 58 3.65(1.28-10.37)    
 Multiparous 6(6.7) 84(93.3) 90     
Booking status     18.08 1 0.00* 
 Unbooked 10(41.7) 14(58.3) 24 6.47(2.51-16.66)    
 Booked 18(9.9) 163(90.1) 181     
IPTpSP use     18.08 1 0.00* 
 No 10(41.7) 14(58.3) 24 6.47(2.51-16.66)    
 Yes 18(9.9) 163(90.1) 181     
IPTpSP dose     10.62 2 0.01* 
 One 8(24.2) 25(75.8) 33 13.76(1.63-
116.54) 
   
 Two 9(8.7) 95(91.3) 104 4.07(0.50-33.17)    
 Three and 
above 
1(2.3) 43(97.7) 44     
ITN use     0.71 1 0.40 
 No 16(15.7) 86(84.3) 102 1.41(0.63-3.15)    
 Yes 12(11.7) 91(88.3) 103     
Insecticide 
spray 
    0.38 1 0.54 
 No 9(16.1) 47(83.9) 56 1.31(0.55-3.10)    
 Yes 19(12.8) 130(87.2) 149     
Mosquito coil 
use 
    1.95 1 0.16 
 No 24(15.6) 130(84.4) 154 2.17(0.72-6.58)    
 Yes 4(7.8) 47(92.2) 51     
Door/ window 
netting 
    2.30 1 0.13 
 No 0(0.0) 11(100.0) 11 2.52(0.74-8.54)    
 Yes 28(14.4) 166(85.6) 194     
Malaria drug 
treat. 
    0.86 1 0.36 
 No 22(15.1)) 124(84.9) 146 1.57(0.60-4.09)    
 Yes 6(10.2) 53(89.8) 59     
MP =Placental malaria parasitaemia; OR = Odds Ratio; CI = confidence interval; X2 = Chi 
square value 
df = Degree of freedom; * = significant association (P<0.05); empl. Stat.= employment 
status; educ. Stat. = educational status; IPTpSP = intermittent preventive treatment with 
sulphadoxine-pyrimethamine; 
ITN = Insecticide-Treated Net; treat = treatment 
 
Discussion 
 The socio-demographic profile of the participants showed patronage 
from the more educated and affluent women. It is likely that, because of the 
higher hospital charges in tertiary hospitals, a good number of the less 
educated and poorer women patronize the primary and secondary health care 
centres with lower hospital charges. The predominant tribe and religion in the 
European Scientific Journal March 2018 edition Vol.14, No.9 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
254 
area of study were Ijaw and Christianity respectively; this was reflected in the 
preponderance of Ijaw and Christian women in the study. The older maternal 
age predominance may have also accounted for the preponderance of 
parturients that were multiparous. 
 Concerning the utilization of malaria preventive measures among the 
parturients, the contributory factors to the non-use of malaria 
chemoprophylaxis with sulphadoxine-pyrimethamine as well as use of less 
than three doses in the course of pregnancy include unbooked status, late 
booking and non-adherence to prescription. While it is possible to have 
women book early for antenatal care by ensuring female education and 
empowerment, administration of sulphadoxine-pyrimethamine as directly 
observed therapy (DOTS) during antenatal visits would prevent non-
compliance to the medication. Because pregnant women in malaria endemic 
areas are among the most vulnerable to the infection, the World Health 
Organization has recommended that all pregnant women should consistently 
sleep under insecticide treated bed nets.(Olumese, 2014) According to the 
Nigerian Demographic Survey of 2013, only 18% of pregnant women slept 
under insecticide treated bed net the night before the survey (an index for its 
consistent use).(National Population Commission [Nigeria] and ICF 
International, 2013) Although the result from this study (30% rate of 
consistent use) is an improvement from the 2013 findings, it is still below the 
recommendation of consistent use among all (100%) pregnant women in 
malaria endemic regions. 
 The prevalence of placental malaria parasitaemia of 13.7% found in 
this study is similar to the prevalence of 14% reported by Mokuolu et al in a 
study from four geopolitical zones in Nigeria(Mokuolu et al., 2009) and that 
(13.0%) reported by Falade et al in south western Nigeria(Falade et al., 2010) 
but much lower than the 65.2% prevalence reported in Portharcourt (Bassey 
et al., 2015) within the same geographical zone with Bayelsa where this study 
was conducted. The lower prevalence in this study may be due to the high 
level of education among the parturients which may have contributed to their 
health awareness with a positive impact on their health and the effective 
malaria preventive measures utilized by the parturients including IPTpSP 
(88.3%) and ITN (50.2%); other factors may include a high level of 
community acquired immunity and the quality of antenatal care.(Bassey et al., 
2015) 
 The finding that Plasmodium falciparum was the only parasite species 
detected in all the placental blood films in this study confirms previous reports 
that placental malaria is an exclusive feature of plasmodium falciparum 
infection in pregnancy(Srivastava et al., 2010) and that Plasmodium 
falciparum is the most prevalent species in Nigeria accounting for about 98% 
of malaria cases in the country(Federal Ministry of Health [Nigeria], 2010) 
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 This study identified maternal age less than 25 years, less than 
secondary level of education, low parity (nulliparity and primiparity), 
unbooked status and non-use of malaria chemoprophylaxis (sulphadoxine-
pyrimethamine) as risk factors for placental malaria parasitaemia. Parturients 
younger than 25 years of age were 5 times more likely to have placental 
malaria parasitaemia than those 25 years and older. This supports the findings 
of previous studies stating young maternal age as a risk factor for placental 
malaria(Idowu & Babalola, 2015; Mokuolu et al., 2009; Okolie et al., 2014) 
which could be attributed to lower levels of acquired immunity as well as the  
lack of pregnancy associated immunity against the placental-binding 
parasites.(Idowu & Babalola, 2015)  
 As observed in the study and although not an independent risk factor, 
parturients who had none or primary level of education were 3 times more 
likely to have placental malaria compared to parturients with at least secondary 
level of education. High educational standards usually affect health awareness 
and therefore has a positive impact on health.(Ogbu et al., 2015) The reverse 
may be the case in those with lower standards of education as they may not 
appreciate the burden of malaria in pregnancy and the importance of adherence 
to stipulated malaria preventive measures because of their limited 
understanding and knowledge. 
 Multiparous women in malaria-endemic regions are believed to form 
blocking antibodies that bind to placental chondroitin sulphate A during their 
subsequent pregnancies and prevent placental sequestration of Plasmodium 
falciparum.(Maestre & Carmona-Fonseca, 2014) This explains why the 
burden of malaria in pregnancy is higher among women of low parity 
(nulliparity and primiparity) and is supported by findings from this study that 
demonstrated low parity as an independent risk factor for placental malaria 
parasitaemia. The result suggested that nulliparous and primiparous women 
individually had a three-fold risk for placental malaria compared to 
multiparous women. Similar findings have been reported by researchers in 
Portharcourt, Nnewi and Ile Ife in Nigeria.(Bassey et al., 2015; Fehintola et 
al., 2016; Okolie et al., 2014) 
 As a component of the malaria preventive measures during pregnancy, 
the Nigerian Federal Ministry of Health has recommended the use of at least 
three doses of sulphadoxine-pyrimethamine combination with each dose given 
not less than 4 weeks apart in the second and third trimesters of 
pregnancy.(Federal Ministry of Health [Nigeria], 2014) Not receiving 
intermittent preventive treatment in pregnancy, identified as an independent 
risk factor in this study increased the risk of placental malaria parasitaemia by 
six times compared to those that received. Several studies have reported 
similar findings.(Bassey et al., 2015; Fehintola et al., 2016; Idowu & Babalola, 
2015) Also, among the parturients who had malaria chemoprophylaxis with at 
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least a dose of sulphadoxine-pyrimethamine combination during pregnancy, 
receiving at least three doses was more protective than receiving 2 doses (Odds 
Ratio of 0.25) or one dose (Odds Ratio of 0.07). The contributory factors for 
receiving less than the recommended doses include unbooked status, late 
booking, non- compliance with prescription and possibly, unavailability of the 
medication at the time of desired purchase from pharmacy stores (as at the 
time of this study, the drug was not being administered as directly observed 
therapy in the study location). Provision of the medication at the antenatal 
clinic and administration as directly observed therapy (DOT) coupled with 
adequate female education and empowerment would likely eliminate the 
above stated factors. 
 While several studies have demonstrated the non-use of insecticide 
treated bed nets by pregnant women as a risk factor for placental malaria 
parasitaemia,(Ezebialu et al., 2012; Idowu & Babalola, 2015) this study did 
not. A common habit in the study area of sitting out till late at night before 
retiring to sleep in a bid to ‘get fresh air’ and avoid the heat inside the houses 
especially during the protracted periods of interrupted power supply that 
prevents the use of fans or air conditioners, is likely to expose individuals to 
mosquito bites and undermine the effectiveness of sleeping under insecticide 
treated bed nets. This may explain the contrary finding in this study. 
 Malaria in pregnancy is still a public health problem. The level of 
utilization of the preventive measures is still far from what is desired. The 
results of this study, adds justification for advocacy from all stakeholders to 
promote the utilization of malaria preventive measures during pregnancy in 
order to achieve a reduction in the burden of the disease. 
 
Conclusion  
 Malaria during pregnancy is still an important public health problem 
in our obstetric population with a high prevalence of placental malaria 
parasitaemia and the significant contributors include low maternal age, low 
educational status, low parity, unbooked status and non-use of intermittent 
preventive treatment in pregnancy. Women should be educated and 
empowered financially and encouraged to register for antenatal care during 
pregnancy. There should be a prompt switch to the recent WHO 
recommendation regarding malaria prophylaxis in pregnancy and the 
medication should be given as Directly Observed Therapy.  
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